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g.2012.1Abstract The prevalence of obesity, insulin resistance and type 2 diabetes has steadily increased in
the last decades. In addition to the genetic and environmental factors, gut microbiota may play an
important role in the modulation of intermediary phenotypes leading to metabolic disease. Infection
is an important cause of morbidity and mortality in diabetic patients. Chronic hyperglycemia
impairs host defense mechanism such as cell mediated immunity, polymorphonuclear leukocyte
function, and antibody formation. So we aimed to study the association between intestinal micro-
ﬂora (Lactobacillus acidophilus) count and phagocytic activity of polymorphonuclear leukocytes in
humans with type 2 diabetes.
The study included 20 type 2 diabetic patients with good glycemic control and 20 type 2 diabetic
patients with poor glycemic control. In addition, 20 normal healthy subjects were included as
normal controls. The fecal composition of L. acidophilus was detected using de Man Rogosa Sharp
agar followed by further conﬁrmation using the polymerase chain reaction technique. Phagocytic
function of polymorphonuclear leukocytes was assessed using the phagocytosis index %. Fecal
L. acidophilus count was signiﬁcantly increased among uncontrolled diabetic patients, while the
phagocytosis index % was signiﬁcantly reduced among the same patients. In uncontrolled diabetics,
a signiﬁcant positive correlation was observed between fecal L. acidophilus count and HbA1c and aEl Bahrin Street, Merryland,
1004204.
(R.Y. Shahin).
Shams University.
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96 F.H. Abo Ali et al.signiﬁcant negative correlation between phagocytic activity andL. acidophilus count. In conclusion,
type 2 diabetes is associated with compositional changes in fecal L. acidophilus especially in the
uncontrolled diabetes. The levels of glucose tolerance or severity of diabetes should be considered
while linking the level of intestinal microbiota with a phagocytosis index of leukocytes.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Type 2 diabetes is the most common form of diabetes that ac-
counts for 85–95% of all diabetes in developed countries with
a higher proportion in developing countries [1]. Infection in
diabetic patients is severe, prolonged and difﬁcult to treat so
it is an important cause of morbidity and mortality in those
patients. Infection is responsible for 6.0% of diabetic deaths
[2].
Intestinal microbiota is the largest source of microbial stim-
ulation that exerts both harmful and beneﬁcial effects on
human health. It therefore acts as a primary agent as it partic-
ipates in the development of the postnatal immune system as
well as oral tolerance and immunity [3].
The recently explored impact of the microbiota on energy
metabolism, gut hormone regulation and the gut–brain axis
was judged to be a fascinating topic and of great value in
the future; however, the current limited human data do not al-
low the suggestion that probiotics can have a clinical role in
the management of obesity or diabetes [4].
The Genus Lactobacillus represents a heterogeneous group
with well documented immunomodulating properties and
might potentially contribute to chronic inﬂammation in dia-
betic subjects [5].
Probiotics increase neutrophil bactericidal activity, phago-
cytosis, and oxidative burst. Bacteria, such as Lactobacillus
acidophilus, increase lymphocyte numbers in the gut [6]. Other
studies, also, report that supplementation with L. acidophilus
in healthy subjects signiﬁcantly increased the phagocytic activ-
ity of polymorphonuclear cells [7].
Most of the published studies described the differences be-
tween gut microbiota in obese compared to lean persons, while
type 2 diabetes is generally considered as an attribute to obes-
ity and thus left far behind as a focus of research. So, the
objective of this study was to evaluate the role of intestinal
microﬂora in the phagocytic activity of polymorphonuclear
leukocytes in diabetic patients.
1.1. Subjects and methods
This case–control study was conducted on 40 patients with
type 2 diabetes who were treated in the out-patient clinics of
Ain Shams University hospitals from June 2009 to June
2010. Furthermore, 20 healthy age and sex matched subjects
were considered as control group. The diagnosis of type 2 dia-
betes was based on the World Health Organization criteria [8].
Selected patients were classiﬁed into two groups: group A
included 20 patients with type 2 diabetes with good glycemic
control (HbA1c: 5.5–6.8%) and group B included 20 patients
with poor glycemic control (HbA1c > 6.8%).
None of the patients had a history of gastrointestinal dis-
eases nor received antibiotics, probiotics and prebiotics, within
30 days prior to sampling. Patients presenting with symptomsof other associated systemic illness or ICU admission were also
excluded.
The Human Research Ethics Committee of Ain Shams Uni-
versity hospital approved this study and informed consent was
obtained from each patient.
All of the patients underwent complete history taking and
physical examination. The body mass index (BMI) was calcu-
lated from the formula: weight (kg)/height (m)2. All subjects
were investigated for the following: complete blood picture,
serum fasting glucose and serum 2 h postprandial glucose lev-
els. HbA1c levels (%) were measured at the time of enrollment
using the fast ion exchange resin separation method (TECO
Diagnostic, Lakeview Ave., Anaheim, CA, USA) and the
methodology was done following the manufacturer’s
instructions.
1.2. Phagocytic index test
Quantitative determination of leukocyte phagocytosis was per-
formed using heparinized venous blood. After centrifugation,
50 ml of the separated buffy coat was mixed with 50 ml of
NBT dye (nitro blue tetrazolium dye) solution. This mixture
was then incubated for one hour followed by ﬁxing and stain-
ing of blood ﬁlm using leishman’s stain. The number of gran-
ulocytes showing phagocytosis under microscope was counted
(the normal range 25–60%) [9].
1.2.1. Stool culture for L. acidophilus
Stool culture on de Man Rogosa Sharp agar (MRS) samples
was collected in the early morning. Quantitative culture for
L. acidophilus was done by weighing part (1 g) of the stool
specimen which was diluted in 2 ml of sterile saline. Serial dilu-
tions of this suspension were prepared in sterile saline solution;
1 ml of each dilution was inoculated into MRS agar plates
using a standard loop. The plates were incubated anaerobically
at 37 C for 2–3 days. Colony forming unit per gram was de-
tected for each stool specimen using the following formula:
CFU=Gm ¼ ND 2
W
where CFU: colony forming unit, Gm: gram, N: the number of
colonies on the plate, D: dilution, W: the weight of the stool
specimen in Gm, and 2: the original dilution of the stool
specimen.
–Bacterial count normal (up to 100,000 CFU/Ml).
1.2.2. Identiﬁcation of L. acidophilus
(1) Colonial morphology: Typical colonies of L. acidophilus
on MRS agar appear as round, small, white, rough,
raised, translucent colonies and catalase negative.
(2) Gram’ staining: L. acidophilus appears gram positive
bacilli or rods arranged in short chains (Image 1).
Image 2 Gel electrophoretic separation of PCR product of 16 S
universal bacterial gene 1500 bp fragment.
Image 3 Gel electrophoresis of Lactobacillus acidophilus gene
ampliﬁcation product at 123 pb fragments (at well 1, 9, 13).
Image 1 Gram stained ﬁlm of Lactobacillus acidophilus by oil
immersion lens.
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acidophilus is distinguished from other lactobacilli by its
inability to ferment lactose, mannitol and sorbitol.
1.2.3. Step2
Further identiﬁcation of L. acidophilus by the PCR technique.
1.2.3.1. DNA isolation. DNA from bacterial colony that grows
in MRS broth was extracted using proteinase K protocol after
centrifugation of the broth for 2 min. Brieﬂy, bacterial cells
were resuspended in 467 ll of freshly prepared (50 mM Tris–
HCl, 10 Mm EDTA, PH 7.5) 30 UL of 10% SDS and 3 ll
of 20 mg/ml proteinase-k, Sigma Aldrich. Following incuba-
tion at 65C for 45 min with shaking, the DNA was obtained
by phenol/chloroform/isoamyl alcohol (25:24:1) precipitated
with isopropanol washed with ethanol (70%) and dried under
vacuum [10]. DNA pellet was resuspended in 25 ll of sterile
distilled water and stored at 20 C.
1.2.3.2. PCR primer. DNA pellet was conﬁrmed to be of bac-
terial origin using the universal 16-S primer. F (5-AGA GTT
TCC TGG CTC TSA AG-3) and R (5-ACG ACC TTG
TTA GMT CGA CTT3) that amplify a 1500 bp fragment.
The genous speciﬁc primers of identiﬁcation of Lactobacilli
were designed on 16SrRNA as described by Dubernet
et al.[11].
The genus speciﬁc primers, (Sigma, USA) for Lactobacilli
ampliﬁes a 123 bp fragment. LbL MA1-rev (5-CTC AAA
ACT AAA CAA AGT TTC-3) and R16-1 (50-CTT GTA
CAC ACC GCC CGT CA-3).
1.2.3.3. PCR conditions and procedure. PCR reaction mixture
(25 ll) was composed of 25 pmol of each primer, 0.2 mM of
each dNTP, 1 · PCR buffer 50 mM Tris–HCl, PH 8.8,
2.5 mM MgCl2, 15 Mm (NH4)2SO4 0.45% Triton X-100,
10 ng of bacterial DNA and 1U of Taq DNA Polymerase (Bio-
tech International, Australia).
The PCR was carried out in a Touchdown Thermal Cycler
(Hybaid Middlesex, UK).
The ampliﬁcation program is as follows: initial denatur-
ation at 95 C for 5 min, followed by 30 cycles consisting ofdenaturation at 95 C for 30 s, annealing at 55 C for 30 s,
extension at 72 C for 30 s, and a 7 min ﬁnal extension step
at 72 C. Ampliﬁcation products were subjected to electropho-
resis in 1% agarose gels (Electrophoresis grade, Invitrogen) in
TAE buffer (40 mM Tris acetate, 1 mM EDTA, pH 8.2) fol-
lowed by ethidium bromide staining (5 lg ml) and visualized
under UV light as shown in Images 2 and 3.
The strain L. acidophilus ATCC 4356 was used as positive
control.
2. Statistical analysis
Data were analyzed using SPSS (Statistical Program for Social
Sciences) version 12. Data were expressed as mean ± standard
deviation (SD). Data were analyzed using Student’s t-test and
one-way analysis of variance (ANOVA) with post Hoc analy-
sis (Tukey’s test) for the comparison of two and three groups,
respectively. Chi-square test was used to compare categorical
data. Pearson correlation was used for measuring the correla-
tion between the different variables. A p-value of less than 0.05
was considered signiﬁcant.
3. Results
Demographic and clinical characteristics of the studied groups
are shown in Table 1. There were no signiﬁcant differences be-
tween the three groups as regards age and gender. Compared
Table 2 Phagocytosis index % among the study groups.
Group A
(controlled diabetic patients)
Group B
(uncontrolled diabetic patients)
Healthy controls P-value
Phagocytosis index 33.65 ± 6.235 20.90 ± 2.174 38.25 ± 5.398 P< 0.001*
Tukey’s test
Controlled diabetics vs.
uncontrolled diabetics
Controlled diabetics vs.
healthy controls
Uncontrolled diabetics vs.
healthy controls
P< 0.001* P< 0.05* P< 0.001*
* P< 0.05 signiﬁcant.
Table 3 Lactobacillus acidophilus count among the study groups.
Characteristic Group A
(controlled diabetic patients)
Group B
(uncontrolled diabetic patients)
Healthy controls P-value
aLactobacillus a. Count (CFU/ML) 430 ± 212.999 560 ± 153.554 163.75 ± 85.878 P< 0.001**
Tukey’s test
Controlled diabetics vs.
uncontrolled diabetics
Controlled diabetics vs. healthy controls Uncontrolled diabetics vs.
healthy controls
P< 0.001** P< 0.001** P< 0.05**
a CFU, colony forming unit.
** P< 0.05 signiﬁcant.
Table 1 Demographic, clinical characteristics and biochemical parameters of the study groups.
Group A
(controlled diabetic patients)
N= 20
Group B
(uncontrolled diabetics patients)
N= 20
Controls N= 20 P-value
Age (years) 52.70 ± 6.79 52.95 ± 7.96 53 ± 1 >0.05
Gender no (%) >0.05
Male 8 (40%) 10 (50%) 10 (50%)
Female 12 (60%) 10 (50%) 10 (50%)
BMIa 34.18 ± 5.87 32.26 ± 1.67 27.01 ± 2.3 0.001**
Total leukocytic count (103/cmm) 6.455 ± 1.318 5.672 ± 1.956 5.625 ± 1.245 >0.05
PMNLa 55 ± 3 56 ± 4 54 ± 2 >0.05
Fasting blood glucose (mg/dl) 122.15 ± 10.86 200.35 ± 34.961 81.23 ± 8.273 <0.001**
Postprandial blood sugar (mg/dl) 162.15 ± 9.3 303.3 ± 43.552 122.81 ± 12.139 <0.001**
All values are expressed as mean ± SD except gender which is expressed as no. (%).
a BMI, body mass index; PMNL, polymorph nuclear leukocytosis.
** P< 0.05 signiﬁcant.
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higher BMI, fasting blood glucose and postprandial blood glu-
cose levels. Total leukocytic count and PMNL did not differ
signiﬁcantly between the study groups. Among diabetic pa-
tients, HbA1c was 6 ± 0.44 among those with good glycemic
control and was 7.3 ± 0.32 among those with poor glycemic
control.
On comparing the phagocytosis index between the three
groups, we observed a signiﬁcant reduction of their values
among uncontrolled diabetic patients (20.90 ± 2.174) than
the controlled diabetic patients and the control group
(33.65 ± 6.235 and 38.25 ± 5.398 respectively) as shown in
Table 2.
We observed on culturing of the stool of the subjects for
microﬂora that the count of L. acidophilus in diabetics wassigniﬁcantly higher than in controls (P=<0.001; means of
495.00 ± 194.738 CFU/ml vs. 163.75 ± 85.878 CFU/ml,
respectively). Further analysis revealed that L. acidophilus
count was higher among uncontrolled diabetics than con-
trolled diabetics and healthy controls as shown in Table 3.
Correlations between L. acidophilus count in stool among
controlled and uncontrolled diabetic patients and the various
studied parameters are shown in Table 4. There was a positive
correlation between L. acidophilus count in stool and plasma
glucose levels (FBS, PPBS, HBA1c), which was observed
among both groups, being more signiﬁcant among the uncon-
trolled group. In addition, L. acidophilus count was negatively
correlated with the phagocytosis index % among both groups
with signiﬁcant correlation among the uncontrolled group.
Regarding the BMI, no correlation was found between the
Table 5 Correlation of phagocytosis index % and the various studied parameters among controlled and uncontrolled diabetics.
Controlled diabetic patients Uncontrolled diabetic patients
r P-value r P-value
Age 0.202 0.392 0.481 0.032
BMIa 0.063 0.792 0.089 0.710
FBSa 0.214 0.36 0.653 0.002**
PPBSa 0.12 0.65 0.517 0.02**
HBA1ca 0.314 0.178 0.804 0.000**
TLCa 0.197 0.406 0.028 0.907
PMNLa 0.220 0.351 0.175 0.459
Lactobacillus acidophilus count 0.031 0.896 0.643 0.002**
a BMI, body mass index; FBS, fasting blood sugar; PPBS, postprandial blood sugar; TLC, total leukocytic count; PMNL, polymorph nuclear
leukocytosis; HbA1C, glycosylated hemoglobin.
** P< 0.05 signiﬁcant.
Table 4 Correlation of Lactobacillus acidophilus count and the various studied parameters among controlled and uncontrolled
diabetics.
Controlled diabetic patients Uncontrolled diabetic patients
r P-value r P-value
Age 0.288 0.218 0.291 0.213
BMIa 0.437 0.054 0.282 0.228
FBSa 0.22 0.34 0.595 0.006**
PPBSa 0.07 0.75 0.621 0.003**
HBA1ca 0.268 0.254 0.681 0.001**
TLCa 0.110 0.644 0.378 0.100
PMNLa 0.167 0.482 0.315 0.176
Phagocytosis index 0.031 0.896 0.643 0.002**
a BMI, body mass index; FBS, fasting blood sugar; PPBS, postprandial blood sugar; TLC, total leukocytic count; PMNL, polymorph nuclear
leukocytosis; HbA1C, glycosylated hemoglobin.
** P< 0.05 signiﬁcant.
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patients.
The phagocytosis index % correlated negatively and signif-
icantly with the values of plasma glucose as determined by
FBS, PPBS and HbA1c among uncontrolled diabetic patients
and negatively, though not signiﬁcantly, with plasma glucose
values among controlled diabetic patients as shown in Table 5.
4. Discussion
Evidence that the gut microbiota composition can be different
between healthy and obese and/or type 2 diabetic patients has
led to the investigation of this environmental element as a key
factor in the pathophysiology of metabolic diseases [12].
The results of this study showed that the signiﬁcantly high-
er levels of the Lactobacillus group in diabetic subjects com-
pared to controls, have also been reported in relation to
type 2 diabetes in mouse models [13] and to obesity in human
adults [14].
It has been proposed that some of the gut microbiota direc-
ted increased monosaccharide uptake from the gut and
instructed the host to increase hepatic production of triglycer-
ides associated with the development of insulin resistance [15].
This is in line with our study which revealed a signiﬁcant
increase in L. acidophilus count in uncontrolled diabetics in
comparison to controlled diabetics as well as signiﬁcant
positive correlation between L. acidophilus counts and HbA1c,fasting blood glucose and 2 h postprandial blood glucose in
uncontrolled diabetics and a signiﬁcant positive correlation
betweenL. acidophilus counts and HbA1c in all diabetics. Fur-
ther explanation for the above ﬁnding was that several studies
have described biomechanical remodeling as well as morpho-
logical remodeling of the gastrointestinal wall in experimental
diabetic rats [16]. Frokjaer et al. [17] have shown that both the
neuronal function of the contractile system as well as the struc-
tural apparatus of the gastrointestinal tract may be affected in
patients with longstanding diabetes mellitus and diabetic auto-
nomic neuropathy (DAN).
On the contrary, Yadav and his colleagues [18] found that
following the administration of L. acidophilus and Lactobacil-
lus casei to high fructose induced type 2 diabetes in rats there
was a decrease in glycogen accumulation in the liver, signiﬁ-
cantly delayed onset of glucose intolerance, hyperglycemia,
hyperinsulinemia, dyslipidemia, and oxidative stress indicating
a lower risk of diabetes and its complications.
Several reports have demonstrated that the gut microbiota
participates in the development of obesity by several mecha-
nisms, i.e., by harvesting energy from the diet, by modulating
the synthesis of gut peptides involved in energy homeostasis,
and/or by regulating fat storage [19].
This study revealed no signiﬁcant correlation between
L. acidophilus counts and body mass index (BMI) in all the
diabetics either controlled or uncontrolled. On the contrary,
Khan et al. [20] reported that in his animal experimental
100 F.H. Abo Ali et al.study, the administration of a single dose of Lactobacillus spp.
was associated with a signiﬁcant weight gain. In another
study, obese patients presented signiﬁcantly higher concentra-
tions of Lactobacillus sp. in their feces than lean controls [21].
Larsen et al. [5] reported that type 2 diabetes mellitus was
associated with compositional changes in the intestinal micro-
biota, as obese diabetics presented signiﬁcantly higher levels
of Lactobacillus sp. Moreover, Thuny and his associates [22]
found that treatment with vancomycin in humans resulted
in a major and signiﬁcant weight gain as they speculated that
the weight gain was induced by the growth promoting effect
of Lactobacillus sp. in patients who had been treated by van-
comycin, as these bacteria are known to be resistant to
glycopeptide.
Chronic hyperglycemia can impair a wide range of func-
tions in neutrophils including chemotaxis, adherence, phagocy-
tosis, intracellular killing, superoxide anion O2, hydrogen
peroxide H2O2 and sorbital production. This is consistent with
many studies which conﬁrmed that clinical investigations of
diabetic and experimental studies of diabetic rats and mice
have clearly demonstrated consistent defects in PMN
chemotactic, phagocytic, and antimicrobial activities [23].
Regarding the association of phagocytic index with HbA1c,
fasting blood glucose and postprandial blood glucose, we
found that there is a highly signiﬁcant negative correlation of
phagocytosis index with HBA1c and a signiﬁcant negative cor-
relation with fasting and postprandial blood sugar in uncon-
trolled diabetics. This is in agreement with Alba-Loureiro et
al. [24] who stated that the reduction in leukocyte phagocytosis
and bactericidal activity showed a signiﬁcant correlation with
increases in blood glucose levels. The reduction of blood
glucose levels by insulin treatment of diabetic patients has been
reported to be signiﬁcantly correlated with improvement of
neutrophil phagocytosis capacity [2].
This ﬁnding conﬁrmed that chronic hyperglycemia impairs
phagocytic function of neutrophils and this contributes to the
high susceptibility to and severity of infections in diabetes
mellitus.
This study is the ﬁrst and the only available one to correlate
between phagocytic activity and L. Acidophilus counts in dia-
betic patients. In uncontrolled diabetics, we found a signiﬁcant
negative correlation. While in controlled diabetics, there was
no signiﬁcant correlation.
In conclusion, no one can judge the true link between
diabetes mellitus and gut microbiota, if it is a cause or an out-
come. It was known that high fat feeding changed the gut mic-
robiota toward decreasing the number of beneﬁcial bacteria
together with an increase in the number of hazardous bacteria
resulting in a state of metabolic endotoxaemia which might
trigger an inﬂammatory response and play a role in the devel-
opment of diabetes. The exact mechanism by which gut micro-
biota lowers systemic inﬂammatory tone is poorly understood
and needs further investigations.Acknowledgements
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